ELAVL1 and lung carcinoma: A siRNA against HuR was loaded into a folic acid (FA)-conjugated polyamidoamine dendrimer (Den)-based nanoparticle, and this formulation was found to effectively decrease HuR expression and cell proliferation in lung cancer cells.